FIELD: medicine.
SUBSTANCE: aspects of the present invention relate to a nasal spray formulation containing at least one active pharmaceutical ingredient, glycerol, polyethylene glycol and dextrose.
EFFECT: compositions according to the present invention provide a moisturizing effect and retain at least about 3% of water under the action of a relative humidity of about 80% at a temperature of about 23 °C for approximately 750 minutes in the study by dynamic vapour sorption (DVS).
8 cl, 17 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NASAL PHARMACEUTICAL COMPOSITIONS AND METHODS OF APPLICATION THEREOF | 2004 |
|
RU2380090C2 |
| AXELASTIN AND STEROIDS COMBINATION | 2003 |
|
RU2361593C2 |
| STABLE PHARMACEUTICAL COMPOSITION WITH FIXED DOSE, CONTAINING MOMETASONE AND OLOPATADINE | 2014 |
|
RU2687551C2 |
| ANTIVIRAL AND VIROCIDAL NOSAL SPRAY COMPOSITIONS AND RELATED TREATMENTS | 2020 |
|
RU2795218C1 |
| TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADIN | 2014 |
|
RU2799761C2 |
| TREATMENT OF ALLERGIC RHINITIS USING COMBINATION OF MOMETASONE AND OLOPATADINE | 2014 |
|
RU2686670C2 |
| CORTICOSTEROID-CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR TREATING EOSINOPHILIC ESOPHAGITIS | 2014 |
|
RU2678695C2 |
| COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS | 2013 |
|
RU2652352C2 |
| COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL DEPENDENCE | 2017 |
|
RU2767062C2 |
| PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE AND USE THEREOF | 2013 |
|
RU2663117C2 |
